Faez Amokrane Nait Mohamed, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alginates | 2 | 2017 | 252 | 0.670 |
Why?
|
| Scorpion Venoms | 2 | 2018 | 31 | 0.670 |
Why?
|
| Drug Carriers | 1 | 2016 | 693 | 0.400 |
Why?
|
| Antibody Formation | 1 | 2016 | 1402 | 0.390 |
Why?
|
| Nanoparticles | 2 | 2017 | 1905 | 0.330 |
Why?
|
| Influenza A virus | 1 | 2022 | 456 | 0.330 |
Why?
|
| Scorpions | 2 | 2018 | 4 | 0.310 |
Why?
|
| Vaccines | 1 | 2016 | 822 | 0.300 |
Why?
|
| Hexuronic Acids | 2 | 2017 | 144 | 0.290 |
Why?
|
| Glucuronic Acid | 2 | 2017 | 148 | 0.290 |
Why?
|
| Influenza Vaccines | 1 | 2022 | 738 | 0.250 |
Why?
|
| Influenza, Human | 1 | 2022 | 1479 | 0.190 |
Why?
|
| AIDS Vaccines | 1 | 2023 | 938 | 0.140 |
Why?
|
| Lethal Dose 50 | 1 | 2016 | 77 | 0.140 |
Why?
|
| Erythema | 1 | 2017 | 257 | 0.140 |
Why?
|
| Edema | 1 | 2017 | 789 | 0.110 |
Why?
|
| Rabbits | 2 | 2018 | 4894 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 1375 | 0.100 |
Why?
|
| Nanotechnology | 1 | 2017 | 710 | 0.100 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2022 | 157 | 0.100 |
Why?
|
| Adjuvants, Immunologic | 1 | 2016 | 1000 | 0.090 |
Why?
|
| Immunoglobulin G | 2 | 2018 | 4560 | 0.080 |
Why?
|
| Vaccination | 1 | 2017 | 3278 | 0.060 |
Why?
|
| Calcium | 1 | 2016 | 5756 | 0.050 |
Why?
|
| Mice | 4 | 2023 | 81183 | 0.050 |
Why?
|
| HIV Antigens | 1 | 2023 | 347 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2022 | 1978 | 0.050 |
Why?
|
| Cytokines | 1 | 2017 | 7322 | 0.050 |
Why?
|
| Animals | 5 | 2023 | 168757 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2018 | 4445 | 0.050 |
Why?
|
| Alleles | 1 | 2022 | 6933 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 3176 | 0.050 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2023 | 548 | 0.050 |
Why?
|
| Saponins | 1 | 2018 | 50 | 0.040 |
Why?
|
| Freund's Adjuvant | 1 | 2018 | 139 | 0.040 |
Why?
|
| Immune Sera | 1 | 2018 | 641 | 0.040 |
Why?
|
| HIV Infections | 1 | 2023 | 16718 | 0.040 |
Why?
|
| Immunization Schedule | 1 | 2018 | 221 | 0.040 |
Why?
|
| Vaccines, Attenuated | 1 | 2018 | 342 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2018 | 1588 | 0.030 |
Why?
|
| Immunization | 1 | 2018 | 1256 | 0.030 |
Why?
|
| Antigens | 1 | 2018 | 1466 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2023 | 9734 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2023 | 4665 | 0.020 |
Why?
|
| Antibodies | 1 | 2018 | 2460 | 0.020 |
Why?
|
| Humans | 3 | 2023 | 744343 | 0.010 |
Why?
|
| Female | 2 | 2018 | 380194 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 18029 | 0.010 |
Why?
|